BLR Bio is a privately held biotechnology business with a focus on orphan and specialty fibrotic diseases.
BLR Bio has raised $780K in total funding. The most recent round was Grant. The last funding was announced in February 2023.
BLR Bio's investors include Canadian Institutes of Health Research.
BLR Bio is headquartered in Kenosha, United States.
BLR Bio is a privately held biotechnology business with a focus on orphan and specialty fibrotic diseases.
BLR Bio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BLR Bio — Funding & Investors." VCBacked, February 14, 2023, https://www.vcbacked.co/company/blr-bio. Accessed August 13, 2026.
VCBacked. (2023). BLR Bio — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/blr-bio
{{cite web |title=BLR Bio — Funding & Investors |url=https://www.vcbacked.co/company/blr-bio |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated